Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Randy H Thurman

Director at Outlook Therapeutics, Inc. (OTLK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$845
Total bought / sold$2K / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 27SEC OTLKOutlook Therapeutics, Inc. Buy 5,0005,593 held (+843%) $0.43 $2K +39.3%
  • Buy

    Director Randy H Thurman bought $2K of OTLK at $0.43 — first open-market purchase in our records; raises the stake by 843%.